Notices. DEPARTMENT OF HEALTH AND HUMAN SERVICES

814 words·~4 min read·/register/2022/10/03/2022-21330·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, And Blood Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* National Heart, Lung, and Blood Institute Special Emphasis Panel;

Contract Review Meeting 1. *Date:* November 1, 2022. *Time:* 9 a.m. to 2:30 p.m. *Agenda:* To review and evaluate contract proposals. *Place:* National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting). *Contact Person:* Zhihong Shan, Ph.D., M.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 205-J, Bethesda, MD 20892,

(301)827-7085, *zhihong.shan@nih.gov.* *Name of Committee:* National Heart, Lung, and Blood Institute Special Emphasis Panel; Scientific Opportunities for Exploratory Research (R21). *Date:* November 1, 2022. *Time:* 10 a.m. to 5 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, 7605 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting). *Contact Person:* Kazuyo Kegan, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 208-T, Bethesda, MD 20892,

(301)402-1334, *kazuyo.kegan@nih.gov.* *Name of Committee:* National Heart, Lung, and Blood Institute Special Emphasis Panel; Contract Review Meeting 2. *Date:* November 1, 2022. *Time:* 3 p.m. to 5 p.m. *Agenda:* To review and evaluate contract proposals. *Place:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). *Contact Person:* Zhihong Shan, Ph.D., M.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 205-J, Bethesda, MD 20892,

(301)827-7085, *zhihong.shan@nih.gov.* *Name of Committee:* National Heart, Lung, and Blood Institute Special Emphasis Panel; Research Education Program to Enhance Diversity. *Date:* November 2, 2022. *Time:* 1 p.m. to 4 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting). *Contact Person:* Shelley Sehnert, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Suite 208-T, Bethesda, MD 20817,

(301)827-7984, *ssehnert@nhlbi.nih.gov.* *Name of Committee:* National Heart, Lung, and Blood Institute Special Emphasis Panel; NHLBI Contract Review. *Date:* November 7, 2022. *Time:* 10 a.m. to 12 p.m. *Agenda:* To review and evaluate contract proposals. *Place:* National Institute of Health, Rockledge I, 6705 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). *Contact Person:* Manoj Kumar Valiyaveettil, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 208-R, Bethesda, MD 20817,

(301)402-1616, *manoj.valiyaveettil@nih.gov.* *Name of Committee:* National Heart, Lung, and Blood Institute Special Emphasis Panel; Catalyze: Product Definition. *Date:* November 9, 2022. *Time:* 10 a.m. to 3 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting). *Contact Person:* Kristin Goltry, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 209-B, Bethesda, MD 20892,

(301)435-0297, *goltrykl@mail.nih.gov.* *Name of Committee:* National Heart, Lung, and Blood Institute Special Emphasis Panel; ARDS, Pneumonia, and Sepsis Phenotyping Consortium. *Date:* November 14-15, 2022. *Time:* 11 a.m. to 5 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting). *Contact Person:* Susan Wohler Sunnarborg, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National, Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 208-Z, Bethesda, MD 20892,

(301)827-7987, *susan.sunnarborg@nih.gov.* *Name of Committee:* National Heart, Lung, and Blood Institute Special Emphasis Panel; Catalyze: Product Definition. *Date:* November 15, 2022. *Time:* 10 a.m. to 4 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting). *Contact Person:* Manoj K. Valiyaveettil, Ph.D., Scientific Review Officer, Blood & Vascular Branch, Office Scientific Review, Division of Extramural Research Activities (DERA), National Institute of Health, National Heart, Lung, and Blood Institute, Bethesda, MD 20817,

(301)402-1616, *manoj.valiyaveettil@nih.gov.* (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: September 27, 2022. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022-21330 Filed 9-30-22; 8:45 am]